Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Wu

Showing results (71-80 of 2,347) with videos related to

Pageof 235
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
N-Cyclo-hexyl-2-oxo-2-phenyl-acetamideZe-Jun Jia, Jin-Long Wu
Biochemical Genetics|September 28, 2005
Mitochondrial DNA genetic diversity of black muntjac (Muntiacus crinifrons), an endangered species endemic to ChinaHai-Long Wu, Sheng-Guo Fang
Sensors (Basel, Switzerland)|January 8, 2025
Research on Tool Wear Monitoring Technology Based on Variational Mode Decomposition and Back Propagation Neural Network ModelKang Wang, Aimin Wang, Long Wu
Journal of Thoracic Disease|February 13, 2019
Adjuvant TKIs: still an optimal choiceSi-Yang Liu, Yi-Long Wu
Journal of Hematology & Oncology|July 7, 2017
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in ChinaSi-Yang Liu, Yi-Long Wu
Oncotargets and Therapy|December 16, 2020
Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with <i>EGFR-</i>Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial ProgramHai-Yan Tu, Yi-Long Wu
Organic Letters|July 10, 2008
Comparative inhibition studies of enoyl-CoA hydratase 1 and enoyl-CoA hydratase 2 in long-chain fatty acid oxidationLong Wu, Shuping Lin, Ding Li
Future Oncology (London, England)|September 15, 2020
Afatinib for the first-line treatment of <i>EGFR</i> mutation-positive NSCLC in China: a review of clinical dataHai-Yan Tu, Yi-Long Wu
Medicine|March 17, 2020
Removal of intracardiac bone cement embolism after percutaneous kyphoplasty: A case reportYu Song, Xiaofan Huang, Long Wu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2024
"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLCMei-Mei Zheng, Yi-Long Wu
Pageof 235

Showing results (71-80 of 2,347) with videos related to

Sort By:
Pageof 235
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
N-Cyclo-hexyl-2-oxo-2-phenyl-acetamideZe-Jun Jia, Jin-Long Wu
Biochemical Genetics|September 28, 2005
Mitochondrial DNA genetic diversity of black muntjac (Muntiacus crinifrons), an endangered species endemic to ChinaHai-Long Wu, Sheng-Guo Fang
Sensors (Basel, Switzerland)|January 8, 2025
Research on Tool Wear Monitoring Technology Based on Variational Mode Decomposition and Back Propagation Neural Network ModelKang Wang, Aimin Wang, Long Wu
Journal of Thoracic Disease|February 13, 2019
Adjuvant TKIs: still an optimal choiceSi-Yang Liu, Yi-Long Wu
Journal of Hematology & Oncology|July 7, 2017
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in ChinaSi-Yang Liu, Yi-Long Wu
Oncotargets and Therapy|December 16, 2020
Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with <i>EGFR-</i>Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial ProgramHai-Yan Tu, Yi-Long Wu
Organic Letters|July 10, 2008
Comparative inhibition studies of enoyl-CoA hydratase 1 and enoyl-CoA hydratase 2 in long-chain fatty acid oxidationLong Wu, Shuping Lin, Ding Li
Future Oncology (London, England)|September 15, 2020
Afatinib for the first-line treatment of <i>EGFR</i> mutation-positive NSCLC in China: a review of clinical dataHai-Yan Tu, Yi-Long Wu
Medicine|March 17, 2020
Removal of intracardiac bone cement embolism after percutaneous kyphoplasty: A case reportYu Song, Xiaofan Huang, Long Wu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2024
"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLCMei-Mei Zheng, Yi-Long Wu
Pageof 235